Eurofins CDMO Alphora is developing and launching AI-powered software for high-throughput salt and co-crystal screening.

Designed to balance ease of use, cost efficiency, and reproducible data, which are critical requirements for successful high-throughput screening campaigns ...

Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Axion BioSystems, a leading life sciences tools company focused on cutting-edge live-cell bioelectronic assay and imaging ...

Metrion Biosciences ("Metrion"), the specialist preclinical contract research organization (CRO) and a global leader in ion channel services, today announced the launch of its validated, ...

Recently, nanoparticle-driven 3D bioprinting has emerged as a revolutionary approach for high-throughput drug screening, offering enhanced scalability, accuracy, and efficiency while reducing reliance ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

Metrion Biosciences, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Validated drug discovery assay ...